Type 2 Diabetes Drugs Can Skip Cardiovascular Outcome Trials, But Phase III Must Be Longer, Broader

 
• By Sue Sutter
  
type 2 diabetes. Treatment and prevention of disease. Syringe and vaccine. Medical concept. Selective focus
US FDA has outlined a new development paradigm for type 2 diabetes drugs. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet